ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7,801 | 75.51794 | 1 | male | 0 | 6 | 77 | Colon Cancer | Cancer | 1 | 8 | $11-$25k | 0 | 2,927 | 2,886.5352 | 0 | 12 | white | 13.699219 | 20 | 0.840942 | 0.651978 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 112 | null | 73 | 16 | 37 | null | null | null | 1 | 136 | null | null | null | null | 2 | null | null | 1.839 |
7,802 | 79.17297 | 1 | female | 0 | 9 | 56 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 26 | 10,831 | 8,347.8672 | 0 | 22.5 | white | 19.898438 | 38 | 0.745972 | 0.665894 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 9 | 73 | 11.298828 | 120 | 28 | 38 | 272.5 | 2.799805 | 0.299988 | 1 | 138 | 7.089844 | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
7,803 | 52.45398 | 0 | male | 0 | 5 | 1,980 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | $11-$25k | 0 | 4,430 | 3,420.4375 | 0 | 11 | white | 14.398438 | 24 | 0.930908 | 0.881958 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 5 | 59 | 6.699219 | 46 | 24 | 36 | null | 4.299805 | 0.399963 | 1.199951 | 137 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
7,804 | 47.978 | 0 | male | 0 | 4 | 1,980 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $25-$50k | 0 | 2,944 | 2,810.1133 | 0 | 14 | white | 17.898438 | 18 | 0.916992 | 0.860962 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 4 | 60 | null | 67 | 16 | 36.29688 | null | null | null | 1.399902 | 132 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,805 | 78.09998 | 1 | female | 0 | 8 | 185 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 4,045 | 3,967.3262 | 0 | 5.5 | white | 16.597656 | 27 | 0.840942 | 0.738892 | 1 | 0 | 0 | no | 0.95 | 0.85 | no dnr | 8 | 77 | 7.199219 | 74 | 28 | 36.19531 | 336 | 3.399902 | 0.099991 | 0.799927 | 137 | 7.379883 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
7,806 | 64.40198 | 1 | male | 0 | 17 | 23 | Lung Cancer | Cancer | 2 | 13 | $11-$25k | 0 | 11,896 | 9,567.375 | 0 | 12.666664 | white | 13.699219 | 14 | 0.769897 | 0.522949 | 1 | 0 | 0 | metastatic | 0.9 | 0.2 | no dnr | 17 | 76 | null | 74 | 20 | 36.59375 | null | null | null | null | 140 | null | null | null | null | null | null | <2 mo. follow-up | 2.886719 |
7,807 | 52.57797 | 1 | female | 0 | 8 | 17 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 3,866 | 3,825.4043 | 0 | 11.5 | white | 21.796875 | 21 | 0.634888 | 0.324951 | 1 | 0 | 0 | metastatic | 0.5 | 0.25 | dnr after sadm | 1 | 100 | 23.5 | 68 | 26 | 35.39844 | 280.9375 | 2.799805 | 0.5 | 0.899902 | 137 | 7.529297 | null | null | null | 5 | 4 | <2 mo. follow-up | 4 |
7,808 | 64.112 | 1 | male | 0 | 3 | 895 | Colon Cancer | Cancer | 2 | 12 | under $11k | 0 | 9,439 | 6,126.6133 | 0 | 24 | white | 17.199219 | 17 | 0.816895 | 0.60498 | 1 | 1 | 0 | metastatic | 0.95 | 0.5 | no dnr | 3 | 70 | 8.798828 | 56 | 20 | 36.19531 | null | null | null | 1.199951 | 137 | null | null | null | null | 0 | 2 | no(M2 and SIP pres) | 2 |
7,809 | 35.25497 | 0 | male | 0 | 12 | 1,978 | CHF | COPD/CHF/Cirrhosis | 1 | 12 | $11-$25k | 0 | 9,425 | 8,858.6172 | 0 | 11.5 | white | 16.398438 | 9 | 0.94397 | 0.903931 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 12 | 110 | 7.099609 | 71 | 20 | 36 | 300 | 3.299805 | 0.699951 | 1.199951 | 138 | 7.469727 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
7,810 | 75.08795 | 1 | female | 0 | 6 | 188 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 12 | null | 0 | 2,721 | 2,737.4766 | 0 | 7 | white | 18.398438 | 18 | 0.723999 | 0.56897 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 97 | 4.399414 | 80 | 24 | 36.59375 | null | 2.799805 | 4.699219 | 0.699951 | 141 | null | null | null | null | 3 | null | no(M2 and SIP pres) | 2.511099 |
7,811 | 61.16098 | 1 | male | 0 | 12 | 24 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,474 | 5,262.7461 | 0 | 12 | white | 19.199219 | 20 | 0.671997 | 0.372986 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | no dnr | 12 | 113 | 3.399902 | 96 | 24 | 35.89844 | 392.5625 | null | null | 1.599854 | 137 | 7.489258 | null | null | null | 2 | 5 | <2 mo. follow-up | 5 |
7,812 | 60.62399 | 0 | male | 0 | 6 | 1,973 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 3,184 | 3,054.2676 | 0 | 6 | white | 16.597656 | 19 | 0.725952 | 0.452942 | 1 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 6 | 78 | null | 63 | 16 | 36.29688 | null | null | null | 1.399902 | 138 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,813 | 38.18997 | 1 | female | 0 | 5 | 274 | Lung Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 3,008 | 2,698.291 | 0 | 7 | white | 15.099609 | 6 | 0.794922 | 0.566895 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 5 | 97 | null | 93 | 16 | 36.59375 | null | null | null | 0.899902 | 140 | null | null | null | null | 3 | 0 | no(M2 and SIP pres) | 0 |
7,814 | 60.52298 | 1 | male | 0 | 5 | 146 | Lung Cancer | Cancer | 2 | 12 | $25-$50k | 0 | 3,019 | 2,819.0898 | 0 | 9 | white | 21.199219 | 25 | 0.628906 | 0.317993 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | no dnr | 5 | 103 | null | 118 | 28 | 37 | null | null | null | 0.899902 | 133 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
7,815 | 63.52597 | 1 | female | 0 | 19 | 71 | Lung Cancer | Cancer | 2 | 14 | >$50k | 0 | 9,732 | 9,939.6406 | 0 | 7 | white | 18.296875 | 15 | 0.684937 | 0.391968 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 19 | 102 | 6 | 64 | 24 | 35.89844 | null | 3.399902 | 0.399963 | 0.699951 | 137 | null | null | null | null | 1 | 2 | null | 2 |
7,816 | 51.62997 | 1 | female | 0 | 21 | 195 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 26,097 | 21,064.1406 | 0 | 24.333328 | white | 19.199219 | 23 | 0.893921 | 0.855957 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 21 | 62 | 14.099609 | 81 | 20 | 35.79688 | 252 | 5.199219 | 0.299988 | 1 | 131 | 7.429688 | null | null | null | null | null | null | 2.212402 |
7,817 | 53.24799 | 1 | male | 0 | 16 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 9 | $11-$25k | 9 | 31,599 | 24,138.4062 | 0 | 20.666656 | white | 24.398438 | 27 | 0.782959 | 0.712891 | 5 | 0 | 0 | no | 0.75 | 0.75 | dnr after sadm | 13 | 129 | 16.5 | 99 | 28 | 37.79688 | 145.4375 | null | null | 0.899902 | 134 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,818 | 69.23798 | 1 | male | 0 | 12 | 529 | Lung Cancer | Cancer | 1 | null | null | 0 | 5,094 | 4,922.6289 | 0 | 9 | white | 19.296875 | 7 | 0.648926 | 0.34198 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 83 | null | 107 | 20 | 36.09375 | null | null | null | 0.799927 | 137 | null | null | null | null | null | null | null | 2.822754 |
7,819 | 64.08997 | 1 | female | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 25,603 | 17,680.8281 | 0 | 43 | white | 22.199219 | 20 | 0.81189 | 0.748901 | 3 | 0 | 0 | no | null | null | dnr after sadm | 5 | 119 | 21.199219 | 106 | 10 | 36.89844 | 260 | 2.599609 | 0.399963 | 1.399902 | 130 | 7.459961 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
7,820 | 71.56696 | 0 | male | 0 | 8 | 1,964 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 37 | 7,708 | 6,010.5898 | 0 | 26.5 | white | 22.199219 | 24 | 0.690918 | 0.523926 | 1 | 0 | 0 | no | null | null | no dnr | 8 | 97 | 16.199219 | 104 | 16 | 37.59375 | 116 | 4.199219 | 1 | 1.599854 | 137 | 7.429688 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,821 | 64.64899 | 1 | male | 0 | 13 | 75 | Lung Cancer | Cancer | 4 | 13 | $11-$25k | 0 | 7,133 | 6,788.6484 | 0 | 12 | white | 16.699219 | 8 | 0.714966 | 0.435974 | 1 | 0 | 0 | metastatic | 0.8 | 0.2 | no dnr | 13 | 82 | null | 96 | 16 | 36.29688 | null | null | null | 1 | 135 | null | null | null | null | null | 0 | null | 0 |
7,822 | 33.03497 | 0 | male | 0 | 24 | 1,958 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 44 | 34,366 | 25,804.8906 | 0 | 27.666656 | white | 25 | 46 | 0.790894 | 0.7229 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 24 | 63 | 11 | 168 | 40 | 39.39844 | 250 | 2.099609 | 0.099991 | 0.599976 | 136 | 7.479492 | null | null | null | null | 4 | adl>=4 (>=5 if sur) | 4 |
7,823 | 37.84799 | 1 | male | 1 | 60 | 60 | MOSF w/Malig | ARF/MOSF | 1 | 20 | $25-$50k | 0 | 153,931 | 108,927.438 | 21,095.6094 | 47.75 | white | 35.59375 | 60 | 0.352966 | 0.235992 | 9 | 0 | 0 | yes | null | null | dnr after sadm | 55 | 107 | 0.899902 | 112 | 12 | 39.39844 | 232.5 | 3.299805 | 4.799805 | 6.5 | 141 | 7.40918 | null | null | null | null | 4 | null | 4 |
7,824 | 72.54999 | 0 | male | 0 | 47 | 1,956 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 9 | 7,980 | 58,163.2188 | 2,981.35938 | 38.75 | white | 28.199219 | 52 | 0.634888 | 0.532959 | 3 | 0 | 0 | no | 0.2 | 0.2 | no dnr | 47 | 62 | 23.796875 | 130 | 10 | 36.69531 | 198 | 2.099609 | 4.799805 | 1.5 | 142 | 7.399414 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
7,825 | 47.15399 | 1 | female | 0 | 6 | 130 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 1,495 | 1,585.3633 | 0 | 8 | white | 14.898438 | 12 | 0.782959 | 0.545898 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 74 | 3.699707 | 104 | 16 | 36.89844 | null | 3.599609 | 0.399963 | 1.099854 | 137 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,826 | 46.74298 | 1 | male | 0 | 5 | 484 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 15 | $11-$25k | 0 | 4,862 | 3,947.4746 | 0 | 6 | white | 22.597656 | 22 | 0.822998 | 0.711914 | 1 | 1 | 0 | no | null | null | no dnr | 5 | 63 | 6.099609 | 51 | 24 | 36.09375 | 361.875 | 3.599609 | 3.199707 | 0.599976 | 135 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,827 | 66.69397 | 1 | female | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 50,034 | 35,662.0938 | 0 | 34.333313 | white | 33.296875 | 66 | 0.451965 | 0.33197 | 10 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 17 | 67 | 10.798828 | 156 | 8 | 37.79688 | 116 | null | null | 2.299805 | 132 | 7.589844 | null | null | null | null | null | <2 mo. follow-up | 2.143555 |
7,828 | 71.24695 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 11,031 | 7,678.4141 | 0 | 55 | white | 28.796875 | 42 | 0.699951 | 0.608887 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 4 | 63 | 7.099609 | 98 | 12 | 39.59375 | 150 | 2.899902 | 0.899902 | 7.699219 | 129 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 2.087891 |
7,829 | 74.78998 | 1 | female | 1 | 213 | 213 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 305,357 | 240,289.875 | 160,055.5 | 45.25 | white | 24.597656 | 25 | 0.611938 | 0.505981 | 22 | 1 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 15 | 63 | 18.199219 | 106 | 12 | 38 | 120 | 2.599609 | 0.699951 | 0.799927 | 142 | 7.469727 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,830 | 59.32098 | 1 | male | 0 | 6 | 7 | COPD | COPD/CHF/Cirrhosis | 1 | 8 | $11-$25k | 0 | 3,759 | 3,812.2266 | 0 | 7 | white | 19.796875 | 43 | 0.888916 | 0.814941 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 1 | 111 | 5.799805 | 122 | 32 | 36.69531 | 160.84375 | 4.099609 | 0.299988 | 1.099854 | 140 | 7.449219 | null | null | null | 4 | 6 | <2 mo. follow-up | 6 |
7,831 | 33.19397 | 1 | male | 0 | 12 | 1,253 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 0 | 11,717 | 9,524.1484 | 0 | 20.5 | white | 29.699219 | 31 | 0.831909 | 0.774902 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 12 | 99 | 11.298828 | 118 | 36 | 38.59375 | 98.32812 | 3 | 0.5 | 0.799927 | 139 | 7.30957 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
7,832 | 54.31897 | 1 | female | 1 | 6 | 6 | Coma | Coma | 0 | 12 | $11-$25k | 89 | 10,406 | 7,773.2188 | 0 | 35 | white | 22.597656 | 29 | 0.411987 | 0.338989 | 1 | 0 | 0 | no | null | null | dnr after sadm | 5 | 79 | 11.798828 | 70 | 30 | 38.39844 | 148 | 3.599609 | 2.199707 | 0.699951 | 137 | 7.479492 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
7,833 | 71.13794 | 0 | female | 0 | 10 | 1,943 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 4,705 | 5,213.4844 | 0 | 7.5 | white | 23 | 45 | 0.803955 | 0.68396 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 61 | 8.398438 | 64 | 28 | 35.89844 | 447.5625 | null | null | 2.5 | 137 | 7.459961 | null | null | null | 3 | 0 | no(M2 and SIP pres) | 0 |
7,834 | 57.681 | 1 | male | 0 | 7 | 28 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 2,993 | 3,229.3281 | 0 | 10 | white | 31.296875 | 25 | 0.358948 | 0.078995 | 1 | 0 | 0 | metastatic | 0.9 | 0.5 | dnr after sadm | 1 | 77 | 13.699219 | 120 | 20 | 38.19531 | 272 | 2.599609 | 0.899902 | 0.699951 | 133 | 7.479492 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
7,835 | 78.27795 | 0 | male | 0 | 8 | 1,941 | COPD | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 4,964 | 4,387.3906 | 0 | 10.5 | white | 20.699219 | 52 | 0.783936 | 0.653931 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 8 | 128 | 20.796875 | 64 | 26 | 36.69531 | 180.9375 | 4.299805 | 0.699951 | 2.399902 | 138 | 7.379883 | null | null | null | null | null | null | 3.163574 |
7,836 | 53.5 | 1 | female | 0 | 3 | 139 | Lung Cancer | Cancer | 2 | 8 | under $11k | 0 | 3,024 | 2,026.7148 | 0 | 11 | white | 13.699219 | 11 | 0.78894 | 0.555908 | 1 | 0 | 0 | metastatic | 0.75 | 0.1 | no dnr | 3 | 98 | 15.5 | 74 | 20 | 36.09375 | null | 3.899902 | 0.5 | 0.899902 | 132 | null | null | null | null | 2 | 0 | adl>=4 (>=5 if sur) | 0 |
7,837 | 83.17596 | 1 | male | 1 | 14 | 14 | COPD | COPD/CHF/Cirrhosis | 2 | 6 | $11-$25k | 0 | 7,633 | 7,289.1836 | 0 | 4 | white | 12.599609 | 32 | 0.860962 | 0.770996 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 1 | 67 | 13.5 | 102 | 28 | 38 | 278.25 | 4.399414 | 0.399963 | 1.299805 | 137 | 7.419922 | null | null | null | 1 | 1 | <2 mo. follow-up | 1 |
7,838 | 76.65399 | 1 | female | 0 | 4 | 673 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 7,349 | 5,321.2695 | 0 | 24 | white | 22 | 25 | 0.773926 | 0.639893 | 1 | 1 | 0 | no | 0.98 | 0.95 | no dnr | 4 | 105 | null | 68 | 24 | 36 | 186 | null | null | 2 | 136 | 7.40918 | null | null | null | null | null | no(M2 and SIP pres) | 2.979004 |
7,839 | 65.54095 | 1 | female | 0 | 24 | 231 | CHF | COPD/CHF/Cirrhosis | 3 | 10 | under $11k | 0 | 19,670 | 19,666.4375 | 4,681.42969 | 9 | white | 26.296875 | 46 | 0.777954 | 0.645996 | 1 | 1 | 0 | no | 0.3 | 0.1 | no dnr | 24 | 60 | 7 | 24 | 36 | 35.39844 | 271.375 | 3.599609 | 0.699951 | 1.399902 | 131 | 7.479492 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
7,840 | 60.36697 | 1 | male | 0 | 15 | 499 | Lung Cancer | Cancer | 2 | 10 | under $11k | 0 | 11,616 | 9,475.8438 | 1,852.08984 | 14 | white | 20.898438 | 14 | 0.635986 | 0.325989 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 15 | 100 | 3.5 | 100 | 20 | 36.19531 | null | 3.199707 | 0.199982 | 0.699951 | 139 | null | null | null | null | 5 | 5 | no(M2 and SIP pres) | 5 |
7,841 | 73.86694 | 1 | male | 0 | 17 | 1,474 | Colon Cancer | Cancer | 1 | 12 | under $11k | 0 | 12,604 | 11,720.6719 | 2,091.09961 | 6.333332 | white | 12.5 | 17 | 0.856934 | 0.680908 | 1 | 0 | 0 | metastatic | 0.99 | 0.5 | no dnr | 17 | 71 | 9.298828 | 64 | 16 | 36.59375 | null | 3.699707 | 0.299988 | 0.899902 | 136 | null | null | null | null | 1 | null | null | 1.1669 |
7,842 | 71.60596 | 0 | female | 0 | 36 | 1,931 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 8 | under $11k | 0 | 102,027 | 87,378.1875 | 15,046.5078 | 29.25 | white | 27.199219 | 34 | 0.630981 | 0.527954 | 42 | 0 | 0 | no | null | null | no dnr | 36 | 68 | 8.898438 | 120 | 28 | 38.19531 | 192.5 | 2.699707 | 2 | 0.699951 | 127 | 7.439453 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
7,843 | 70.54095 | 1 | female | 0 | 16 | 42 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 8 | null | 0 | 31,484 | 25,302.75 | 1,520.14941 | 10.666664 | white | 27.398438 | 43 | 0.650879 | 0.55188 | 13 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 1 | 62 | null | 5.299805 | 32 | 38.19531 | null | null | null | 1.699951 | 133 | null | null | null | null | null | null | <2 mo. follow-up | 3.505859 |
7,844 | 83.66895 | 1 | female | 1 | 9 | 9 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 5,823 | 5,288.7266 | 0 | 15 | white | 20.597656 | 36 | 0.689941 | 0.522949 | 1 | 0 | 0 | yes | null | null | no dnr | 9 | 103 | 5.399414 | 112 | 32 | 37.5 | 238.09375 | 3 | 0.199982 | 1 | 141 | 7.40918 | null | null | null | 0 | 2 | <2 mo. follow-up | 2 |
7,845 | 67.74298 | 1 | female | 1 | 9 | 9 | COPD | COPD/CHF/Cirrhosis | 4 | 15 | $11-$25k | 9 | 12,086 | 8,880.1875 | 2,712.79883 | 36.5 | white | 24.097656 | 33 | 0.775879 | 0.642944 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 9 | 71 | 7.799805 | 110 | 8 | 37.79688 | 100 | 3.799805 | 0.799927 | 1.299805 | 133 | 7.469727 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,846 | 57.71899 | 1 | female | 0 | 7 | 448 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 4,462 | 4,133.8125 | 513.15967 | 10 | white | 15.398438 | 33 | 0.754883 | 0.497986 | 1 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 7 | 106 | 4.299805 | 76 | 76 | 36.79688 | null | 3.799805 | 0.299988 | 1 | 132 | null | null | null | null | 0 | 0 | null | 0 |
7,847 | 68.55597 | 0 | female | 0 | 9 | 1,924 | COPD | COPD/CHF/Cirrhosis | 0 | 6 | null | 0 | 4,447 | 4,356.1719 | 2,240.70898 | 10 | white | 25.296875 | 37 | 0.775879 | 0.642944 | 1 | 0 | 0 | no | 0.7 | 0.55 | no dnr | 9 | 75 | 13.298828 | 76 | 24 | 36.29688 | 74.0625 | null | null | 1.199951 | 140 | 7.299805 | null | null | null | 4 | 5 | no(M2 and SIP pres) | 5 |
7,848 | 29.50899 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 33,162 | 22,278.0781 | 13,506.4297 | 41 | white | 26.097656 | 22 | 0.879883 | 0.837891 | 1 | 0 | 0 | no | 0.8 | 0.8 | dnr after sadm | 11 | 78 | 6.5 | 104 | 24 | 38.59375 | 100 | 2.899902 | 0.699951 | 0.599976 | 136 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,849 | 74.32697 | 1 | male | 0 | 13 | 77 | Lung Cancer | Cancer | 2 | 8 | >$50k | 0 | 7,749 | 7,208.8281 | 3,823.54883 | 7 | white | 14.398438 | 21 | 0.735962 | 0.467957 | 1 | 0 | 0 | metastatic | 0.8 | 0.2 | no dnr | 13 | 97 | 7.299805 | 104 | 20 | 36.39844 | null | 4 | 0.899902 | 1.5 | 133 | null | null | null | null | 1 | 0 | adl>=4 (>=5 if sur) | 0 |
7,850 | 83.047 | 1 | female | 0 | 15 | 76 | Colon Cancer | Cancer | 2 | null | null | 0 | 12,151 | 10,807.6719 | 6,059.44922 | 19.666656 | white | 32.195313 | 33 | 0.427979 | 0.121994 | 1 | 0 | 0 | metastatic | 0.15 | 0.1 | no dnr | 15 | 60 | 8.699219 | 58 | 28 | 35.79688 | 142.84375 | 3.099609 | 1.299805 | 1 | 129 | 7.429688 | null | null | null | null | null | null | 3.634766 |
7,851 | 66.57397 | 0 | male | 0 | 6 | 1,921 | COPD | COPD/CHF/Cirrhosis | 2 | 9 | under $11k | 0 | 3,834 | 3,461.3555 | 1,499.34961 | 13 | white | 18.898438 | 25 | 0.868896 | 0.782959 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 6 | 107 | 12.199219 | 122 | 24 | 36.19531 | 232 | 4.299805 | 0.5 | 1 | 130 | 7.30957 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,852 | 67.521 | 0 | male | 0 | 38 | 1,922 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 79,564 | 63,266.0312 | 28,228.3281 | 24.25 | white | 35.195313 | 48 | 0.454956 | 0.253967 | 28 | 0 | 0 | no | null | null | no dnr | 38 | 100 | null | 114 | 40 | 39.29688 | 136.71875 | 2.299805 | 0.699951 | 1.5 | 134 | 7.399414 | null | null | null | null | 3 | no(M2 and SIP pres) | 3 |
7,853 | 71.59497 | 1 | male | 0 | 15 | 90 | Lung Cancer | Cancer | 2 | 8 | under $11k | 0 | 6,543 | 7,237.9766 | 5,261.40625 | 4.666664 | white | 14 | 20 | 0.748901 | 0.488953 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 67 | 4.5 | 43 | 18 | 36.19531 | null | 4.399414 | 0.699951 | 0.699951 | 128 | null | null | null | null | 1 | 0 | null | 0 |
7,854 | 68.93396 | 1 | male | 1 | 75 | 75 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 121,309 | 89,989.5625 | 87,966.625 | 32 | white | 30.699219 | 40 | 0.671997 | 0.575928 | 1 | 0 | 0 | no | 0.7 | 0.7 | dnr after sadm | 75 | 50 | 13.798828 | 130 | 12 | 38.39844 | 146.125 | 2.099609 | 0.899902 | 0.899902 | 140 | 7.489258 | null | null | null | null | 2 | adl>=4 (>=5 if sur) | 2 |
7,855 | 69.61499 | 1 | male | 0 | 5 | 7 | Coma | Coma | 0 | 8 | $11-$25k | 89 | 4,395 | 4,332.0352 | 1,491.97949 | 4 | white | 18.597656 | 24 | 0.372986 | 0.299988 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 111 | 12.298828 | 67 | 36 | 39 | 198.5625 | 4.299805 | 0.699951 | 1 | 140 | 7.379883 | null | null | null | null | null | <2 mo. follow-up | 2.094238 |
7,856 | 78.91595 | 1 | male | 1 | 23 | 23 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $25-$50k | 0 | 16,501 | 12,762.3359 | 10,480.2266 | 11.333328 | white | 27.199219 | 58 | 0.695923 | 0.530884 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 56 | 12.199219 | 77 | 32 | 35.59375 | 323.75 | 3.799805 | 0.299988 | 3.299805 | 132 | 7.529297 | null | null | null | 1 | 5 | <2 mo. follow-up | 5 |
7,857 | 58.18799 | 1 | male | 0 | 21 | 187 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 23,590 | 16,798.2969 | 17,012.75 | 21.333328 | white | 25.296875 | 17 | 0.680908 | 0.586914 | 1 | 1 | 0 | yes | null | null | no dnr | 21 | 107 | 6.399414 | 76 | 24 | 35 | 147.5 | null | null | 0.599976 | 138 | 7.339844 | null | null | null | 6 | 5 | adl>=4 (>=5 if sur) | 5 |
7,858 | 79.56696 | 1 | male | 0 | 8 | 9 | Coma | Coma | 2 | 8 | under $11k | 89 | 68,703 | 52,034 | 19,768 | 37 | white | 20.398438 | 38 | 0.117996 | 0.072998 | 19 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 2 | 76 | 7.599609 | 70 | 6 | 38.09375 | 313.3125 | 3.299805 | 5.5 | 2 | 139 | 7.509766 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
7,859 | 84.75598 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | under $11k | 9 | 19,689 | 14,387.6172 | 12,647.9141 | 32.5 | white | 22.296875 | 28 | 0.682983 | 0.588989 | 5 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 11 | 71 | 12.099609 | 106 | 24 | 38.59375 | 280 | 3.599609 | 0.699951 | 1.799805 | 132 | 7.419922 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
7,860 | 77.23199 | 1 | female | 0 | 16 | 19 | Lung Cancer | Cancer | 1 | 12 | null | 0 | 10,536 | 9,141.625 | 8,242.52344 | 6.333332 | white | 47.296875 | 50 | 0.011 | 0 | 1 | 0 | 0 | metastatic | 0.05 | 0.000125 | no dnr | 16 | 65 | 20.097656 | 107 | 28 | 35.59375 | 200 | 1.599854 | 1.799805 | 0.899902 | 136 | 7.509766 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
7,861 | 76.38098 | 1 | male | 0 | 23 | 25 | Colon Cancer | Cancer | 1 | 9 | under $11k | 0 | 20,869 | 15,689.7109 | 14,394.9844 | 19 | white | 14.599609 | 16 | 0.827881 | 0.626953 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 16 | 98 | 8.699219 | 82 | 20 | 36.59375 | null | null | null | 1.299805 | 136 | null | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
7,862 | 64.05194 | 1 | male | 0 | 7 | 1,789 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | $25-$50k | 0 | 7,054 | 5,307.9805 | 4,175.14844 | 11 | white | 11.398438 | 23 | 0.929932 | 0.880981 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 7 | 72 | 7.699219 | 83 | 22 | 36.59375 | 372 | 4.099609 | 1.399902 | 1.299805 | 136 | 7.509766 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,863 | 80.03595 | 1 | male | 0 | 9 | 536 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 4,391 | 3,785.9277 | 3,023.29883 | 9 | white | 16.796875 | 17 | 0.851929 | 0.755981 | 1 | 0 | 0 | no | 0.95 | 0.8 | dnr before sadm | -1 | 107 | 5.899414 | 78 | 24 | 35.59375 | 380.9375 | 3.599609 | 1.599854 | 1.299805 | 136 | 7.459961 | null | null | null | 0 | 0 | null | 0 |
7,864 | 72.02197 | 0 | male | 0 | 26 | 1,897 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 76,882 | 51,433.0312 | 56,531.8438 | 29 | white | 28.199219 | 55 | 0.626953 | 0.522949 | 12 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 26 | 63 | 29.097656 | 116 | 46 | 38.89844 | 240.8125 | 3.199707 | 0.799927 | 2.299805 | 133 | 7.399414 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
7,865 | 62.543 | 1 | male | 0 | 10 | 196 | Colon Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 5,456 | 4,397.0312 | 3,600.01953 | 10 | other | 18.398438 | 20 | 0.80188 | 0.578979 | 1 | 0 | 0 | metastatic | null | null | no dnr | 10 | 80 | 10.5 | 68 | 28 | 36.19531 | null | null | null | 1 | 134 | 7.489258 | null | null | null | 0 | null | null | 0.4948 |
7,866 | 54.31097 | 1 | male | 0 | 15 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 100 | 62,864 | 43,044.2812 | 44,239 | 25.666656 | white | 25.097656 | 27 | 0.319946 | 0.205994 | 25 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 13 | 72 | 8.298828 | 77 | 36 | 38.69531 | 122 | null | null | 0.599976 | 130 | 7.439453 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
7,867 | 86.32397 | 1 | female | 0 | 11 | 14 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 8,545 | 6,640.6719 | 6,469.9375 | 20.5 | white | 26.898438 | 41 | 0.664917 | 0.567993 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 56 | 18.296875 | 105 | 24 | 36.19531 | null | 2.799805 | 3.799805 | 1.199951 | 133 | null | null | null | null | null | null | <2 mo. follow-up | 3.15625 |
7,868 | 61.23199 | 1 | female | 0 | 21 | 198 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 15,661 | 12,649.1484 | 13,163.9531 | 13 | white | 17.796875 | 46 | 0.897949 | 0.829956 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 65 | 12 | 126 | 24 | 38.09375 | 180 | 4.099609 | 0.399963 | 1 | 136 | 7.519531 | null | null | null | 5 | null | adl>=4 (>=5 if sur) | 3.855299 |
7,869 | 74.22894 | 1 | female | 0 | 11 | 61 | CHF | COPD/CHF/Cirrhosis | 4 | 8 | null | 0 | 6,582 | 5,642.9492 | 4,164.71875 | 11 | white | 13.099609 | 41 | 0.900879 | 0.833984 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 101 | 8.798828 | 83 | 28 | 36.29688 | 285.6875 | 4 | 0.5 | 1.299805 | 137 | 7.549805 | null | null | null | 3 | 2 | no(M2 and SIP pres) | 2 |
7,870 | 71.01996 | 0 | female | 0 | 10 | 1,889 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 6,888 | 5,454.8125 | 5,304.29688 | 13 | null | 16 | 27 | 0.878906 | 0.79895 | 1 | 0 | 0 | no | null | null | no dnr | 10 | 69 | 10.398438 | 80 | 24 | 36.29688 | 191.28125 | 3.599609 | 0.699951 | 0.799927 | 138 | 7.379883 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
7,871 | 72.50696 | 1 | female | 0 | 8 | 9 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | $11-$25k | 0 | 32,917 | 23,600.4844 | 22,444.875 | 42 | white | 23.796875 | 32 | 0.55896 | 0.362976 | 6 | 0 | 0 | no | null | null | dnr after sadm | 7 | 125 | 16.597656 | 135 | 10 | 38.5 | 198 | 2.599609 | 3.699707 | 1.099854 | 138 | 7.479492 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,872 | 85.90594 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 183,453 | 73,059.375 | 30,414.25 | 24 | white | 29.199219 | 68 | 0.344971 | 0.228973 | 95 | 0 | 0 | no | null | null | dnr before sadm | -88 | 69 | 33.59375 | 74 | 27 | 36.19531 | null | 2.099609 | 11.5 | 2 | 144 | null | null | null | null | null | null | <2 mo. follow-up | 2.773438 |
7,873 | 59.754 | 0 | male | 0 | 5 | 1,887 | Cirrhosis | COPD/CHF/Cirrhosis | 0 | 18 | $25-$50k | 0 | 2,433 | 2,052.5488 | 2,148.16992 | 6 | white | 21.296875 | 22 | 0.771973 | 0.636963 | 1 | 0 | 0 | no | 0.95 | 0.05 | no dnr | 5 | 77 | 22.097656 | 118 | 24 | 38 | 376.1875 | 2.5 | 0.899902 | 0.699951 | 134 | 7.539062 | null | null | null | 0 | 0 | null | 0 |
7,874 | 66.34595 | 0 | female | 0 | 9 | 1,887 | COPD | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 9 | 5,860 | 4,906.1016 | 4,020.01953 | 12 | white | 21.597656 | 38 | 0.777954 | 0.645996 | 1 | 0 | 0 | yes | 0.7 | 0.5 | dnr after sadm | 3 | 66 | 16.097656 | 128 | 28 | 37 | 195.8125 | 3.899902 | 0.5 | 0.799927 | 138 | 7.419922 | null | null | null | 1 | 3 | no(M2 and SIP pres) | 3 |
7,875 | 80.45697 | 1 | male | 0 | 14 | 1,062 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | null | 9 | 30,311 | 21,456.9531 | 19,580.5312 | 23.666656 | white | 23.796875 | 60 | 0.662964 | 0.565918 | 7 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 14 | 77 | 7.599609 | 112 | 28 | 37.79688 | 228.5625 | null | null | 2.299805 | 150 | 7.509766 | null | null | null | null | null | null | 3.166504 |
7,876 | 72.83496 | 0 | male | 0 | 14 | 1,885 | COPD | COPD/CHF/Cirrhosis | 6 | null | null | 0 | 10,872 | 8,019.3438 | 6,922.66797 | 15 | white | 18 | 44 | 0.850952 | 0.753906 | 1 | 1 | 0 | no | 0.75 | 0.6 | dnr after sadm | 1 | 78 | 23.097656 | 126 | 44 | 37.5 | 247.8125 | 4.299805 | 0.5 | 1.199951 | 139 | 7.439453 | null | null | null | null | null | null | 4.150391 |
7,877 | 81.51398 | 0 | female | 0 | 13 | 1,884 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 6,709 | 5,749.2891 | 4,989.08984 | 8.5 | white | 23.5 | 45 | 0.75293 | 0.608887 | 1 | 1 | 0 | no | 0.5 | 0.3 | dnr after sadm | 1 | 61 | 9.699219 | 104 | 24 | 35.59375 | 172 | null | null | 1.299805 | 138 | 7.509766 | null | null | null | 4 | 5 | no(M2 and SIP pres) | 5 |
7,878 | 78.396 | 1 | male | 0 | 11 | 12 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | $25-$50k | 0 | 11,293 | 8,076.2969 | 7,590.22656 | 15.5 | white | 18.898438 | 43 | 0.763916 | 0.625 | 1 | 0 | 0 | yes | 0.2 | 0.05 | dnr after sadm | 1 | 124 | 5.599609 | 114 | 24 | 36.59375 | 200 | 3.799805 | 0.399963 | 1.199951 | 133 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.448731 |
7,879 | 68.60498 | 1 | male | 0 | 8 | 226 | Colon Cancer | Cancer | 1 | 10 | $11-$25k | 0 | 6,653 | 4,879.6797 | 4,990.33984 | 13.5 | white | 15.5 | 8 | 0.829956 | 0.629883 | 1 | 0 | 0 | metastatic | 0.95 | 0.8 | no dnr | 8 | 99 | null | 61 | 24 | 36.39844 | null | null | null | null | 140 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
7,880 | 61.47299 | 1 | male | 0 | 3 | 1,546 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 3,448 | 2,522.4512 | 2,477.50977 | 29 | white | 23.796875 | 23 | 0.820923 | 0.760986 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 3 | 80 | 16.796875 | 67 | 20 | 36.29688 | 126.51562 | 4.699219 | 0.599976 | 1.299805 | 138 | 7.319336 | null | null | null | null | 0 | null | 0 |
7,881 | 56.07397 | 1 | female | 0 | 40 | 958 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 165,585 | 126,004.438 | 710,682 | 30.25 | white | 37.59375 | 79 | 0.454956 | 0.334961 | 31 | 0 | 0 | no | null | null | dnr after sadm | 2 | 63 | 29.699219 | 138 | 13 | 38.29688 | 196.65625 | 3.799805 | 13.798828 | 5.099609 | 142 | 7.379883 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
7,882 | 57.42099 | 1 | male | 0 | 7 | 591 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 7,708 | 5,461.6094 | 4,998.39844 | 13 | white | 15.298828 | 11 | 0.850952 | 0.669922 | 1 | 0 | 0 | metastatic | 0.95 | 0.6 | no dnr | 7 | 107 | 6.699219 | 101 | 20 | 38.09375 | null | null | null | 1 | 135 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
7,883 | 54.98398 | 1 | male | 1 | 11 | 11 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 100 | 15,063 | 10,865.6094 | 10,276.6094 | 17 | white | 36.398438 | 72 | 0.040993 | 0.004 | 1 | 1 | 0 | no | 0.1 | 0.001 | dnr after sadm | 11 | 139 | 15.699219 | 62 | 30 | 35.39844 | 266.625 | 2.199707 | 21.199219 | 3.599609 | 140 | 7.419922 | null | null | null | null | null | <2 mo. follow-up | 4.34375 |
7,884 | 75.422 | 0 | male | 0 | 5 | 1,875 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | null | 0 | 3,121 | 2,554.6328 | 2,038.58984 | 13 | white | 15.898438 | 24 | 0.875 | 0.791992 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 5 | 123 | 6.199219 | 56 | 24 | 35.69531 | 342.8125 | 4 | 0.799927 | 1.399902 | 138 | 7.509766 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
7,885 | 84.97998 | 1 | female | 0 | 22 | 31 | Coma | Coma | 2 | null | null | 44 | 13,639 | 11,426.5 | 8,655.96875 | 13.666664 | white | 25.199219 | 44 | 0.253967 | 0.186981 | 1 | 0 | 1 | no | 0.1 | 0.001 | no dnr | 22 | 99 | 26.597656 | 96 | 40 | 39 | null | 3.199707 | 0.599976 | 2.699707 | 141 | null | null | null | null | null | 7 | <2 mo. follow-up | 7 |
7,886 | 59.45798 | 1 | male | 0 | 3 | 107 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 1,553 | 1,255.5518 | 1,230.0791 | 11 | white | 16.398438 | 17 | 0.73291 | 0.462952 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | dnr after sadm | 1 | 107 | 6.099609 | 24 | 24 | 36.09375 | 457.125 | 4 | 0.299988 | 1.199951 | 136 | 7.639648 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
7,887 | 44.25998 | 1 | female | 0 | 10 | 1,143 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 15 | $11-$25k | 0 | 10,970 | 7,433.0586 | 6,815.72656 | 17 | other | 19.597656 | 15 | 0.904907 | 0.869995 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 10 | 62 | 11.699219 | 62 | 24 | 36 | 271.375 | 3.099609 | 0.199982 | 0.599976 | 141 | 7.449219 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
7,888 | 55.55899 | 0 | female | 0 | 4 | 1,872 | Lung Cancer | Cancer | 4 | 14 | $11-$25k | 0 | 2,302 | 1,812.6016 | 1,555.60938 | 4 | white | 6.599609 | 25 | 0.872925 | 0.714966 | 1 | 0 | 0 | metastatic | 0.99 | 0.99 | no dnr | 4 | 65 | 14 | 65 | 26 | 36.79688 | 309.5 | 4.699219 | 0.699951 | 0.699951 | 135 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 2.103516 |
7,889 | 67.95099 | 1 | female | 0 | 33 | 82 | COPD | COPD/CHF/Cirrhosis | 2 | 4 | under $11k | 0 | 26,722 | 20,023.5625 | 19,698.8281 | 11 | white | 38.296875 | 37 | 0.490967 | 0.28894 | 1 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 1 | 81 | 22.296875 | 110 | 32 | 35.79688 | 147.5 | 2.139648 | 0.799927 | 0.699951 | 134 | 7.40918 | null | null | null | null | 6 | adl>=4 (>=5 if sur) | 6 |
7,890 | 74.15698 | 1 | male | 0 | 5 | 1,009 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 2,651 | 2,370.9727 | 1,644.17969 | 2 | white | 16.898438 | 25 | 0.86792 | 0.780884 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 5 | 63 | 8.398438 | 60 | 24 | 35.69531 | null | 3.699707 | 0.699951 | 1.399902 | 139 | null | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
7,891 | 75.73999 | 0 | female | 0 | 50 | 1,867 | Coma | Coma | 3 | 13 | null | 61 | 62,833 | 44,241.5 | 42,341.375 | 25 | white | 20.898438 | 8 | 0.213989 | 0.151978 | 7 | 1 | 0 | yes | 0.25 | 0.1 | dnr before sadm | -6 | 81 | 12.798828 | 78 | 6 | 36.39844 | 420 | 2.899902 | 0.399963 | 0.699951 | 127 | 7.479492 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
7,892 | 69.67596 | 1 | male | 0 | 10 | 12 | Lung Cancer | Cancer | 3 | 8 | null | 9 | 7,891 | 6,284.1953 | 5,915.72656 | 9.5 | white | 21.699219 | 11 | 0.547974 | 0.225983 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr after sadm | 1 | 87 | 11.099609 | 98 | 22 | 36.39844 | null | 3.199707 | 0.199982 | 0.899902 | 133 | null | null | null | null | 1 | 4 | <2 mo. follow-up | 4 |
7,893 | 60.49597 | 1 | female | 1 | 10 | 10 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | $11-$25k | 0 | 22,177 | 15,144.3828 | 15,246.875 | 45.5 | white | 22.699219 | 29 | 0.74292 | 0.595947 | 1 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 9 | 113 | 21.699219 | 138 | 32 | 38.29688 | 540 | 2.099609 | 1.899902 | 0.799927 | 143 | 7.379883 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,894 | 86.185 | 1 | female | 0 | 10 | 606 | COPD | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 5,999 | 4,802.1836 | 3,841.56836 | 8.5 | white | 13.298828 | 22 | 0.837891 | 0.734985 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 1 | 66 | 6.699219 | 79 | 22 | 36.79688 | 382.5625 | null | null | 1 | 139 | 7.40918 | null | null | null | 2 | null | null | 1.839 |
7,895 | 87.25 | 1 | female | 0 | 3 | 6 | Coma | Coma | 1 | null | null | 61 | 2,891 | 2,500.2188 | 2,290.41992 | 8 | white | 15.099609 | 17 | 0.439941 | 0.365967 | 1 | 0 | 0 | no | null | null | dnr after sadm | 1 | 93 | 7.799805 | 96 | 24 | 37.5 | 276.1875 | 4 | 0.599976 | 1.299805 | 136 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 2.358398 |
7,896 | 70.93994 | 1 | female | 0 | 10 | 19 | Lung Cancer | Cancer | 2 | 12 | null | 0 | 6,611 | 5,093.9492 | 4,903.25 | 6 | white | 27.5 | 26 | 0.424988 | 0.119995 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 69 | 15 | 73 | 28 | 35 | null | 3.399902 | 0.599976 | 0.599976 | 128 | null | null | null | null | 0 | null | <2 mo. follow-up | 0.4948 |
7,897 | 66.74597 | 1 | female | 1 | 5 | 5 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 100 | 4,426 | 3,189.6523 | 3,207.23828 | 14 | white | 34.195313 | 59 | 0.127991 | 0.028 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 52 | 11.398438 | 110 | 30 | 36 | 157.125 | 3.099609 | 0.799927 | 0.799927 | 143 | 7.459961 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
7,898 | 71.745 | 1 | female | 0 | 4 | 10 | Coma | Coma | 0 | 8 | under $11k | 89 | 10,217 | 7,638.0469 | 7,995.45703 | 29 | white | 19.296875 | 12 | 0.301941 | 0.230988 | 2 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 4 | 110 | null | 76 | 12 | 38.59375 | 135.53125 | 3.899902 | 0.699951 | 0.699951 | 136 | 7.5 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
7,899 | 69.26196 | 0 | female | 0 | 11 | 1,860 | COPD | COPD/CHF/Cirrhosis | 1 | 13 | $25-$50k | 26 | 14,092 | 9,658.3047 | 9,800.10938 | 29.5 | white | 17.199219 | 41 | 0.822998 | 0.711914 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 11 | 129 | 11.898438 | 156 | 10 | 38.59375 | 168 | 4.5 | 0.299988 | 1 | 134 | 7.339844 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
7,900 | 76.909 | 1 | male | 0 | 6 | 320 | Lung Cancer | Cancer | 2 | null | null | 0 | 3,340 | 2,626.6504 | 2,225.76953 | 17 | white | 15.699219 | 23 | 0.705933 | 0.421997 | 1 | 0 | 0 | metastatic | 0.7 | 0.2 | no dnr | 6 | 63 | 6.399414 | 76 | 24 | 36.39844 | null | null | null | 1.399902 | 135 | null | null | null | null | null | null | null | 2.317383 |